Cargando…
Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study
Background: The GoBolus study investigated the real-world effectiveness of faster aspart in patients with type 1 diabetes (T1D) using intermittent-scanning continuous glucose monitoring (iscCGM) systems. Methods: This 24-week, multicenter, single-arm, noninterventional study investigated adults with...
Autores principales: | Danne, Thomas, Axel Schweitzer, Matthias, Keuthage, Winfried, Kipper, Stefan, Kretzschmar, Yasmin, Simon, Jörg, Wiedenmann, Tanja, Ziegler, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906866/ https://www.ncbi.nlm.nih.gov/pubmed/32924568 http://dx.doi.org/10.1089/dia.2020.0360 |
Ejemplares similares
-
Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes
por: Thalange, Nandu, et al.
Publicado: (2015) -
Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial
por: Ziegler, Ralph, et al.
Publicado: (2013) -
Continuous infusion versus intermittent bolus of ceftazidime for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2003) -
Labor Epidural Analgesia: Comparison of Two Different Intermittent Bolus Regimes
por: Puthenveettil, Nitu, et al.
Publicado: (2018) -
Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year results from a randomized clinical trial (BOOST
(®) T1)
por: Hirsch, I. B., et al.
Publicado: (2016)